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A case report of a 66 year old male patient with COVID 19 who presented late in the
clinical course and subsequently developed respiratory failure requiring intubation, after
initially experiencing diarrhoea.
ª 2021 The Authors. Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Among those infected with Severe Acute Respiratory Syn-
drome Coronavirus-2 (SARS-CoV-2), 5 to 10% experience severe
disease, only a small subset of these patients require intuba-
tion and mechanical ventilation [1]. In severe cases, SARS-CoV-
2 elicits an excessive host immune response leading to exten-
sive tissue damage similar to the manifestations observed with
MERS and SARS [1e5]. While illness severity is predominantly
associated with older age and underlying comorbidities [1,5],Regional Infectious Dis-
H4 2XU, UK. Telephone
scot.nhs.uk (S. Clifford).
Elsevier Ltd on behalf of The
ivecommons.org/licenses/by-in clinical practice it has proven challenging to predict an
individual’s disease course and the requirement for critical
care support. Here we present a case whose initial manifes-
tation was prolonged diarrhoea alone before presenting to
hospital but persistent fever and new cough precipitated hos-
pitalisation. Though appearing relatively well at first, pro-
gressive deterioration ensued with severe hypoxaemia
requiring mechanical ventilation. The patient has provided
written consent for the publication of this case report and the
use of his radiological images.Case report
A 66-year-old male with a past medical history of type 2
diabetes mellitus, non-valvular atrial fibrillation and prostateHealthcare Infection Society. This is an open access article
nc-nd/4.0/).
Figure 1. Disease course.
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admission) was admitted to a tertiary hospital with a seven-day
history of fever, productive cough and haemoptysis. His regular
medication included metformin, warfarin and tamsulosin. He
was a current smoker and had smoked a pipe for over 20 years.
The patient had developed diarrhoea whilst on a business
trip in Spain and became febrile on the day of his return flight
to Scotland (Figure 1). He then presented to primary care with
fever and cough three days prior to hospital admission and was
prescribed oral amoxicillin for a possible lower respiratory
tract infection.
On presentation to the hospital (Day 15 after the onset of
diarrhoea, Figure 1), he appeared clinically well. His Clinical
Frailty Score was 2 and BMI was 30. His temperature measured
37.8C, respiration rate (RR) of 20 breaths per minute, with
evidence of hypoxia (SpO2 of 87% breathing room air). He was in
atrial fibrillation with a blood pressure of 124/64 mmHg and
ventricular rate of 120 beats per minute, confirmed on an
electrocardiogram. He had fine crepitations in both lung bases.
Neurological and abdominal examinations were unremarkable.
In addition to a lymphopenia of 0.59 10^9/L, he also had a
raised CRP of 109 mg/L (0e5). Minor interstitial opacification in
both mid- and lower zones on a chest radiograph (CXR) sug-
gested interstitial pneumonitis or fibrosis. A combined nasal
and pharyngeal viral swab confirmed SARS-CoV-2 by rtPCR (real
time polymerase chain reaction) with a Ct (Cycle threshold)
value of 34.87. One stool sample was sent and was negative on
routine culture and C. difficile toxin EIA (enzyme immuno-
assay). Oral doxycycline was commenced.
The day following admission (day 16 post symptom onset) he
developed respiratory distress with worsening tachypnoea (RR
30) and an increasing oxygen requirement. He was febrile
(39.2C) though maintained a blood pressure of 148/97mmHg.
Within 36 hours of admission, despite reporting clinical
improvement and comfortably mobilising in his room without
breathlessness,hisoxygenrequirementrose fromanFiO2of0.24
to 0.6 via Venturi mask. This stepwise deterioration correlated
with spikes of fever. A follow up CXR demonstrated worsening
bilateral pulmonary infiltrates and consolidation compared to
admission findings (Figure S1). His antibiotics were escalated
fromoral doxycycline to intravenous amoxicillin-clavulanic acid
andhereceivedapproximately fourhoursof intravenousfluidsat200mlsperhour, atwhichpoint hewas reviewedby the intensive
care team. With PaO2:FiO2 of 137 mmHg he was transferred to
the intensive care unit (ICU) for intubation and mechanical
ventilation. During six days of ICU admission, he was adminis-
tered an intravenous furosemide infusion tomaintain a negative
fluid balance of 500mls. He did not require any cardiac or renal
support. After extubation, he required a further 8 days hospi-
talisation until his discharge home.
Discussion
This case report highlights an unusual initial presentation of
COVID-19 infection, which presented to hospital late (day 15
after the onset of diarrhoea) in the disease course. Whilst he
presented to hospital with relatively mild symptoms, he rapidly
deteriorated with progressive severe hypoxaemia requiring
mechanical ventilation.
One of the prominent features observed in this case was the
lack of correlation between the patient’s presentation and the
severity of hypoxemia. There have been reports of patients
with COVID-19 having different ‘types’ of ARDS [12]. Patients
who require ventilation have relatively preserved lung com-
pliance but severely impaired gas exchange. They develop
severe hypoxaemia without the proportional symptoms of
respiratory distress. It is suggested that the apparent lack of
distress, termed ‘silent hypoxia’, is a result of several factors
including hypocapnic hypoxia, which does not tend to induce
the same degree of respiratory distress [13]. This can result in
patients being seemingly well up until a very severe and acute
deterioration. This has implications for decisions regarding
referral to intensive care within in the hospital, but can make
assessments in the community very challenging.
While we continue to learn more about the disease course of
COVID-19, according to the available literature, the average
duration from symptom onset to clinical deterioration, is five to
six days, and hospitalisation generally occurs around day seven
or eight [1,5e7]. In contrast, this patient had a long course of
illness prior to fever onset, symptoms initially dominated by
diarrhoea alone followed by fever and cough. While approx-
imately 40% of patients may have concurrent gastrointestinal
manifestations related to SARS-CoV-2 [8], less than 10% of
patients have diarrhoea as a presenting complaint without
S. Clifford et al. / Infection Prevention in Practice 3 (2021) 100118 3respiratory symptoms or fever [8,9]. While an alternate
pathogen responsible for diarrhoea cannot be fully excluded as
gastrointestinal symptoms were resolving at the time of
admission and only one stool sample was obtained for diag-
nostic purposes, there is evidence that SARS-CoV-2 can infect
and replicate within the human gut enterocytes [9] and
emerging evidence suggests that diarrhoea may be one of the
under-recognised initial symptoms. Given that GI disturbance
is not currently included in the UK government community
testing criteria, there is a need to improve surveillance of
symptoms to quantify the proportion of acute presentations
with diarrhoea to acute care, and to include gastrointestinal
disturbance in the case definition which requires a screen to be
sent for COVID-19 testing.
Despite multiple risk factors that are associated with
increased severity of illness such as older age, diabetes, car-
diovascular disease and treated prostate cancer, this patient
had a relatively mild course of illness prior to hospitalisation.
Despite having 15 days of symptoms prior to hospital admission,
upper respiratory tract sampling remained positive for SARS-
CoV-2, and the patient deteriorated with respiratory failure
at day 16 post symptom onset. This mirrors data from a sys-
tematic review of 79 studies demonstrating that patients
continue to have detectable virus up to 83 days, although
culturable virus was not identified beyond day 9 [10] s. Viral
RNA shedding was shown to be longer in severe group and
among those over the age of 60y [10,11].
Despite having a relatively high Ct value (on nasopharyngeal
swab) indicating low viral load, this patient developed sudden
respiratory failure within 36 hours. There is evidence suggest-
ing discordance between rtPCR results for nasopharyngeal
swabs versus sputum samples, in particular depending on when
in course of the illness the sample was collected [10,14] Spu-
tum samples were not obtained at the time of respiratory
failure so it is not possible to know if there was ongoing viral
replication in the lower airways. However, this could indicate,
as has been previously suggested, that the lung injury and ARDS
could be associated with an aberrant immune response [5,15].
This is supported by the increased levels of pro-inflammatory
cytokines observed in cases with severe pneumonia, that is
associated with abnormal respiratory signs, and increased
ground glass opacities within the lungs [2,3].
This case emphasises the ongoing challenge posed in clinical
management of patients with COVID-19. The risk of rapid dis-
ease progression in patients with underlying risk factors per-
sists even when presenting late in the disease course with
seemingly mild symptoms, especially lacking common severity
indicators such as dyspnoea, respiratory distress and elevated
CRP. It also highlights the importance of improving symptom
surveillance to increase case detection in the UK for COVID-19
pandemic going forward.
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